Skip to Content


In the US, Enzalutamide (enzalutamide systemic) is a member of the following drug classes: antiandrogens, hormones/antineoplastics and is used to treat Prostate Cancer.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antineoplastic agent

Chemical Name

4-{3-[4-cyano-3-(trifluorometyl)phenyl]-5,5-dimetyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-metylbenzamide (WHO)

Foreign Names

  • Enzalutamidum (Latin)
  • Enzalutamid (German)
  • Enzalutamide (French)
  • Enzalutamida (Spanish)

Generic Names

  • Enzalutamide (OS: USAN, JAN)
  • MDV-3100 (IS)
  • UNII-93T0T9GKNU (IS)

Brand Names

  • Xtandi
    Astellas, Bosnia & Herzegowina; Astellas, Belgium; Astellas, Brazil; Astellas, Canada; Astellas, Czech Republic; Astellas, Estonia; Astellas, Spain; Astellas, Finland; Astellas, France; Astellas, Georgia; Astellas, Croatia (Hrvatska); Astellas, Ireland; Astellas, Japan; Astellas, South Korea; Astellas, Lithuania; Astellas, Latvia; Astellas, Macedonia; Astellas, Norway; Astellas, Portugal; Astellas, Sweden; Astellas, Slovenia; Astellas, Slovakia; Astellas, Turkey; Astellas, United States; Astellas Pharma, Australia; Astellas Pharma, Denmark; Astellas Pharma, United Kingdom; Astellas Pharma, Poland; Astellas Pharma Europe, Iceland; Astellas Pharma Europe, Netherlands; Astellas Pharma Europe, Romania; Astellas Pharma Europe, Serbia; Astellas Pharma Europe BV, Greece; Raffo, Argentina; Tecnofarma, Chile; Tecnofarma, Peru
  • Xtandi 40mg
    Astellas, Hungary; Astellas, Israel; Astellas, Luxembourg; Astellas Pharma, Germany; Astellas Pharma, Oman; Astellas Pharma Europe, Austria
  • Xtandi Soft
    Astellas Pharma, Cyprus; Astellas Pharma Europe BV, Greece


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.